Salt Lake City, Utah, United States Intermountain Ventures appeared to be a CVC structure as part of the corporation.
The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Intermountain Ventures, startups are often financed by U.S. Venture Partners (USVP), Norwest Venture Partners, Sanofi-Genzyme BioVentures.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Health Care. Among the various public portfolio startups of the fund, we may underline Omada Health
Related Funds
| Fund Name | Location |
| Aegon Industrial Fund Management Co. | - |
| Bonjour Holdings | China, Hong Kong, New Territories |
| Choice Capital Partners | - |
| CID Capital | Indiana, Indianapolis, United States |
| Haitong Innovation Capital Management | - |
| Handelsbanken | Stockholm, Stockholm County, Sweden |
| Hongfu Group | - |
| Incubio | Barcelona, Catalonia, Spain |
| Korea Venture Investment Corp | Seoul, Seoul-t'ukpyolsi, South Korea |
| Lichter Investments | - |
| Next Wave/Portfolia Angel Fund | Colorado, Mancos, United States |
| Ontario Ministry of Economic Development | Canada, Ontario, Toronto |
| Sageview Capital | California, Palo Alto, United States |
| Schmidt Family Foundation | - |
| Shenzhen Capital Fortune Investment Management | China, Guangdong, Shenzhen |
| Shidu Zichan | Beijing, China, Haidian |
| Steinmetz Diamonds | New York, New York, United States |
| The Chinese Founders Fund | Beijing, Beijing, China |
| Zhejiang Xianju Pharmaceutical | China, Jiangsu, Taizhou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Vivante Health | $31M | 20 Sep 2023 | Houston, Texas, United States | ||
Noetik | $14M | 07 Sep 2023 | South San Francisco, California, United States | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Axuall | $20M | 31 May 2023 | Cleveland, Ohio, United States | ||
Vivante Health | $16M | 08 Mar 2022 | Houston, Texas, United States | ||
Axuall | $10M | 01 Jul 2021 | Cleveland, Ohio, United States | ||
SomaLogic | $81M | 23 Dec 2020 | Boulder, Colorado, United States | ||
GYANT | $13M | 15 Jul 2020 | San Francisco, California, United States |
– Saama technologies announced a strategic growth investment and will be acquired by Carlyle.
– Saama’s intelligent Life Science Analytics Cloud (LSAC) is used by over 50 pharma and biotech companies on more than 1,500 studies.
– As an end-to-end platform, LSAC provides a unified approach to clinical trial data management and analytics.
– Carlyle has made a strategic growth investment and will acquire a majority stake in the Company.
– A broad co-investor group with several healthcare-focused venture funds, including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle.
– Axuall, a digital professional identity network that enables healthcare providers to share their authenticated credentials and qualifications in real-time, announced that they closed $10.4m in Series A funding led by Flare Capital Partners.
– The round was led by Flare Capital Partners and includes participation from the company’s executive leadership, Intermountain Ventures, University Hospitals Ventures, MedStar Health, Epsilon Health, InHealth Ventures, AV8 Ventures, JumpStart, M25 Ventures, and North Coast Ventures.
– Capital from this financing will be used to accelerate R&D, implementations, sales, and marketing as the company grows its customer base of healthcare organizations.
– “Led by Flare Capital Partners and representing over two dozen healthcare organizations, this financing represents a ringing endorsement from the healthcare community,” said Axuall’s CEO, Charlie Lougheed.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Vivante Health | $31M | 20 Sep 2023 | Houston, Texas, United States | ||
Noetik | $14M | 07 Sep 2023 | South San Francisco, California, United States | ||
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Axuall | $20M | 31 May 2023 | Cleveland, Ohio, United States | ||
Vivante Health | $16M | 08 Mar 2022 | Houston, Texas, United States | ||
Axuall | $10M | 01 Jul 2021 | Cleveland, Ohio, United States | ||
SomaLogic | $81M | 23 Dec 2020 | Boulder, Colorado, United States | ||
GYANT | $13M | 15 Jul 2020 | San Francisco, California, United States |
